Vistin Pharma ASA
OSE:VISTN

Watchlist Manager

Vistin Pharma ASA

OSE:VISTN

Watchlist

Dividends

Price: 24.2 NOK -2.02%

Market Cap: 1.1B NOK

Have any thoughts about
Vistin Pharma ASA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 24.2 NOK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

VISTN Alert

Vistin Pharma ASA

24.2

-0.5 (-2.02%)

52 Week Range	21.1 28.6
Price Target

We'll email you a reminder when the closing price reaches NOK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Vistin Pharma ASA

What unique competitive advantages
does Vistin Pharma ASA hold over its rivals?

What risks and challenges
does Vistin Pharma ASA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Vistin Pharma ASA.

What unique competitive advantages
does Vistin Pharma ASA hold over its rivals?

What risks and challenges
does Vistin Pharma ASA face in the near future?

Summarize the latest earnings call
of Vistin Pharma ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vistin Pharma ASA.

Provide P/S
for Vistin Pharma ASA.

Provide P/E
for Vistin Pharma ASA.

Provide P/OCF
for Vistin Pharma ASA.

Provide P/FCFE
for Vistin Pharma ASA.

Provide P/B
for Vistin Pharma ASA.

Provide EV/S
for Vistin Pharma ASA.

Provide EV/GP
for Vistin Pharma ASA.

Provide EV/EBITDA
for Vistin Pharma ASA.

Provide EV/EBIT
for Vistin Pharma ASA.

Provide EV/OCF
for Vistin Pharma ASA.

Provide EV/FCFF
for Vistin Pharma ASA.

Provide EV/IC
for Vistin Pharma ASA.

What are the Revenue projections
for Vistin Pharma ASA?

How accurate were the past Revenue estimates
for Vistin Pharma ASA?

What are the Net Income projections
for Vistin Pharma ASA?

How accurate were the past Net Income estimates
for Vistin Pharma ASA?

What are the EPS projections
for Vistin Pharma ASA?

How accurate were the past EPS estimates
for Vistin Pharma ASA?

What are the EBIT projections
for Vistin Pharma ASA?

How accurate were the past EBIT estimates
for Vistin Pharma ASA?

Compare the revenue forecasts
for Vistin Pharma ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vistin Pharma ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vistin Pharma ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vistin Pharma ASA compared to its peers.

Compare the P/E ratios
of Vistin Pharma ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Vistin Pharma ASA with its peers.

Analyze the financial leverage
of Vistin Pharma ASA compared to its main competitors.

Show all profitability ratios
for Vistin Pharma ASA.

Provide ROE
for Vistin Pharma ASA.

Provide ROA
for Vistin Pharma ASA.

Provide ROIC
for Vistin Pharma ASA.

Provide ROCE
for Vistin Pharma ASA.

Provide Gross Margin
for Vistin Pharma ASA.

Provide Operating Margin
for Vistin Pharma ASA.

Provide Net Margin
for Vistin Pharma ASA.

Provide FCF Margin
for Vistin Pharma ASA.

Show all solvency ratios
for Vistin Pharma ASA.

Provide D/E Ratio
for Vistin Pharma ASA.

Provide D/A Ratio
for Vistin Pharma ASA.

Provide Interest Coverage Ratio
for Vistin Pharma ASA.

Provide Altman Z-Score Ratio
for Vistin Pharma ASA.

Provide Quick Ratio
for Vistin Pharma ASA.

Provide Current Ratio
for Vistin Pharma ASA.

Provide Cash Ratio
for Vistin Pharma ASA.

What is the historical Revenue growth
over the last 5 years for Vistin Pharma ASA?

What is the historical Net Income growth
over the last 5 years for Vistin Pharma ASA?

What is the current Free Cash Flow
of Vistin Pharma ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vistin Pharma ASA.

VISTN

Balance Sheet

Current Portion of Long-Term Debt

Vistin Pharma ASA
Current Portion of Long-Term Debt

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Vistin Pharma ASA
Current Portion of Long-Term Debt Peer Comparison

Comparables:

PHO

NAVA

SOFTX

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company		Current Portion of Long-Term Debt	CAGR 3Y	CAGR 5Y	CAGR 10Y
V	Vistin Pharma ASA OSE:VISTN	Current Portion of Long-Term Debt N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Photocure ASA OSE:PHO	Current Portion of Long-Term Debt kr0	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
N	Navamedic ASA OSE:NAVA	Current Portion of Long-Term Debt kr52.5m	CAGR 3-Years 363%	CAGR 5-Years 16%	CAGR 10-Years 11%
S	SoftOx Solutions AS OSE:SOFTX	Current Portion of Long-Term Debt N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

Vistin Pharma ASA
OSE:VISTN

Vistin Pharma ASA
Current Portion of Long-Term Debt

Vistin Pharma ASA
Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

See Also

Company

Help

Tools

Stocks

Vistin Pharma ASA OSE:VISTN

Vistin Pharma ASA Current Portion of Long-Term Debt

Vistin Pharma ASA Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis Latest Figures & CAGR of Competitors

See Also

Company

Help

Tools

Stocks

Vistin Pharma ASA
OSE:VISTN

Vistin Pharma ASA
Current Portion of Long-Term Debt

Vistin Pharma ASA
Current Portion of Long-Term Debt Peer Comparison

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors